Why did they stop making losartan?
Nov 3, 2023
Why did they stop making losartan?
The recall of certain products was prompted by the discovery of impurities during the rigorous testing process Losartan a commonly used medication was found to contain NMethylnitrosobutyric acid NMBA an impurity that exceeded the acceptable limits This incident marks the third instance where different types of impurities have led to recalls of such medications The recall of Losartan was initiated as a precautionary measure to safeguard the health and wellbeing of consumers Impurities although present in trace amounts can pose potential health risks over extended periods of usage The presence of NMBA in the affected batches was determined through comprehensive testing which is a crucial part of the quality assurance process These tests ensure that the medications released for public consumption meet the highest safety standards By recalling the affected products the pharmaceutical company demonstrates its commitment to maintaining the highest level of quality and safety Collaboration with regulatory agencies and healthcare professionals plays a vital role in identifying and addressing potential issues promptly The recall process will involve informing healthcare providers distributors and pharmacies to halt the distribution and return the affected batches As the pharmaceutical industry continues to prioritize consumer safety it is crucial for manufacturers to uphold stringent quality control measures and maintain vigilance in detecting and addressing any potential impurities promptly Public awareness and cooperation are also essential in ensuring that individuals who may be using the affected medications are informed about the recall and take appropriate actions in consultation with their healthcare providers
Medicines
For information purposes only. Consult a doctor before taking any medicines.
₹75₹83
₹44₹49
₹23₹25
₹20₹23
₹23₹25
₹28₹31
₹27₹42
₹26₹29
₹35₹40
₹25₹28